Recall Register

Food, drugs, devices › Biosense Webster, Inc.

Device recall: SMARTABLATE RF Generator System, Catalog No. M490006, M490007, M4900106, and M4900107. Product Usage: The use of the SMA

FDA enforcement event 70772 · Class II · initiated 19 Mar 2015 · status Terminated · terminated 17 Jun 2015

DeviceVoluntary: Firm initiated1 product recordIrwindale, CA

Biosense Webster, Inc. (Irwindale, CA) initiated this device recall on 19 Mar 2015; FDA lists 1 product record under event 70772, classified Class II.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 91% of the 1,153 device enforcement events initiated in 2015 carry the same class.

Status: Terminated, terminated 17 Jun 2015. Initiation: voluntary: firm initiated. Biosense Webster, Inc. has 21 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Biosense Webster, Inc., Irwindale, CA.

Reason for recall

"Biosense Webster is recalling the SMARTABLATE Generator System because Biosense Webster has received two complaints reporting that during an RMT procedure the SMARTABLATE RF Generator inadvertently delivered RF energy."

Distribution

"Worldwide Distribution - US Nationwide in the state of: CA, IL, KY, NJ, PA and the countries of: Czech Republic, Denmark, Finland, France, Germany, and Sweden."

Product records

Recall numberProductQuantityClassStatusReport date
Z-1691-2015SMARTABLATE RF Generator System, Catalog No. M490006, M490007, M4900106, and M4900107. Product Usage: The use of the SMART ABLATE Generator and all accessories is indicated in combination with compatible therapeutic catheters for use in conventional intracardiac RF ablation procedures. The SMARTABLATE Foot Pedal is…115 unitsClass IITerminated3 Jun 2015

Context

91%of 2015 device events are Class II1,153 events that year
1product record in this eventfirm median: 1
21events on this register for the firm

Other enforcement events for Biosense Webster, Inc.

InitiatedProduct (first record)TypeClassRecords
5 Jan 2025VARIPULSE Bi-Directional Ablation Catheter REF D141201. The Field Catheter is indicated for use in catheter based cardiaDeviceClass I1
16 Feb 2024CARTO VIZIGO Bi-Directional Guiding Sheath, REF D128502 The CARTO VIZIGOTM Bi-Directional Guiding Sheath is designed to DeviceClass II1
21 Feb 2023Biosense Webster Carto Vizigo Bi-Directional Guiding Sheath, 8.5F(Small), REF D-1385-01-S, RX CE 2797, SterileDeviceClass II2
29 Jun 2022CARTO VIZIGO 8.5F Bi-Directional Guiding Sheath, REF: D138501. Used to introduce various cardiovascular catheters into tDeviceClass II1
26 Feb 2021Biosense Webster, CARTO VIZIGO, Bi-Directional Guiding Sheath, 8.5F (SMALL) C3, REF: D138501, Rx Only, CE 2797, STERILE DeviceClass II3
7 May 2018WaveCrest Left Atrial Appendage (LAA), Occlusion System (32 mm), Catalog Numbers WCR1523 and WCR2523.DeviceClass I1
6 Sep 2017THERMOCOOL SMARTTOUCH SF Uni-Directional Product Codes D-1347-01-S, D-1347-02-S, D-1347-03-SDeviceClass II5
14 Jun 2017SMARTABLATE RF System GeneratorDeviceClass II1
17 May 2017PENTARAY NAV High-Density Mapping Catheter.DeviceClass II2
15 Aug 2016CARTO 3 EP Navigation System and Accessories, Product Codes: FG540000 and FG540000C, Software Versions: v 3.2 , v 4.3 anDeviceClass II1

All 21 events for Biosense Webster, Inc.

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "Biosense Webster is recalling the SMARTABLATE Generator System because Biosense Webster has received two complaints reporting that during an RMT procedure the SMARTABLATE RF Generator inadvertently delivered RF energy."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "Worldwide Distribution - US Nationwide in the state of: CA, IL, KY, NJ, PA and the countries of: Czech Republic, Denmark, Finland, France, Germany, and Sweden."

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 17 Jun 2015. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.